title: Hepatic giant cell carcinoma. An ultrastructural and immunohistochemical study.
abstract: Hepatocellular carcinoma with osteoclast-like giant cells (hepatic giant cell carcinoma [HGCC]) is a rare entity, with only three cases reported. The tumor is histologically similar to giant cell tumor (GCT) of bone, and the origin of the multinucleated giant cells and mononuclear stromal cells has not been determined. The purpose of this report is to present a case of this rare tumor and compare its ultrastructural and immunohistochemical features with those of a conventional GCT of bone. Histologically, the HGCC consists of sheets of osteoclast-like giant cells with a background of mononuclear cells. The giant cells lack the pleomorphism seen in hepatocellular carcinomas with anaplastic giant cells. At the light microscopic level, most of this tumor was nearly identical to a GCT of bone, but several microscopic fields (less than 5% of the tumor) had the histologic appearance of a "usual" hepatocellular carcinoma. The hepatic tumor was negative for HAM 56, epithelial cytokeratins, muramidase, and alpha-1-antitrypsin, with only focal positivity for chymotrypsin in mononuclear and giant cells. The GCT was strongly positive for alpha-1-antitrypsin and chymotrypsin in both the mononuclear and giant cells and showed focal, weak staining for AE1 and AE3 in the mononuclear stromal cells. Ultrastructurally, both mononuclear and giant cells of the HGCC showed features typical of hepatocellular carcinoma. Although the patient presented in this report died, the pattern of growth was different from most hepatocellular carcinomas. The overall histologic features of this tumor are distinctive and appear to justify separating this variant from other types of hepatocellular carcinoma.
authors: Department of Radiation Oncology, University of California, San Francisco.
authors: D L
authors: DL
authors: Hood
authors: T W
authors: TW
authors: Bauer
authors: S A
authors: SA
authors: Leibel
authors: J T
authors: JT
authors: McMahon
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D001859:Bone Neoplasms / Q000473:pathology; D002277:Carcinoma / Q000648:ultrastructure*; D006528:Carcinoma, Hepatocellular / Q000648:ultrastructure*; D002467:Cell Nucleus / Q000473:pathology; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D003593:Cytoplasm / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000648:ultrastructure*; D008854:Microscopy, Electron; D010010:Osteoclasts / Q000473:pathology; D011480:Protease Inhibitors / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D011480:Protease Inhibitors; D002918:Chymotrypsin